Daron Evans

CIK 1411726 · CFO · last filed 2026-03-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.12M

Companies

4

Total Filings

70

Lifetime Open-Market Net

$739.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RZLT CFO 411,462 $4.00 $1.65M $664.7K 18 2026-03-04
NEPH CEO Specialty Renal Products 143,162 $3.34 $478.2K $59.9K 8 2021-06-01
CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted Chief Financial Officer 13,352 $0 4 2011-04-19
CAPRICOR THERAPEUTICS, INC. (NLTX) Delisted Chief Financial Officer 13,352 $13.96 $186.4K $14.7K 9 2010-02-17

Recent Filings · Page 3 of 7

70 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-03-12 NEPH Buy (P) +2,500 $16.6K EDGAR
2020-03-05 NEPH Buy (P) +2,500 $21.1K EDGAR
2020-02-05 NEPH Grant (A) $0 EDGAR
2019-12-18 NEPH Grant (A) +9,282 $0 EDGAR
2019-11-18 NEPH Buy (P) +1,000 $8.3K EDGAR
2019-08-22 NEPH Buy (P) +2,000 $13.8K EDGAR
2019-08-13 Grant (A) $0
2019-06-14 Buy (P) +43,172 $25.8K
2018-12-18 Grant (A) +108,296 $0
2018-05-14 Exer (X) +40,000 $12.0K
Showing 2130 of 70
Page 3 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.